FDA issued a Warning Letter to Amgen, Inc. on 1/27/2014 for a previous inspection.
483 Amgen May 2015

483 Amgen May 2015

Jennifer Gogley FDA, Carla Lundi FDA$119.00 - Available Now

FDA investigators audited the Amgen - Thousand Oaks, CA, United States facility and issued 3 inspectional observations (via FDA 483) on 22 May 2015.

Product details

  • Category: Human Drugs
  • Number of Observations: 3
  • Inspection end: 22 May 2015
  • Location: Thousand Oaks, United States
  • FEI: 2026154
Add To Cart